Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 16
Asset Purchase 16
Aspen to Acquire Remaining Rights to Anaesthetic Portfolio from Astrazeneca 16
Aspen Japan Acquires Four Ethical Drug Brands from Kyowa Hakko Kirin 17
Aspen Pharmacare Acquires Anaesthesia Portfolio from GlaxoSmithKline 18
Aspen Global to Acquire Rights to Hydroxyprogesterone Caproate Injection form McGuff Pharma 19
Aspen Pharmacare Acquires Southern African Operations and Product Rights from Norgine 20
Aspen Pharmacare Plans to Acquire Infant Nutrition Business 21
Aspen Pharmacare to Acquire Rights to Mono-Embolex from Novartis 22
Aspen Pharma Acquires Infant Nutritional Businesses from Nestle for USD180 Million 23
Aspen Acquires Portfolio of Drugs from Merck for USD600 Million 25
Aspen Pharmacare Completes Acquisition of Thrombosis Brands And Manufacturing Facility from GlaxoSmithKline for USD1.13 Billion 28
Aspen Acquires Active Pharmaceutical Ingredients Business From Merck 30
Aspen Completes Acquisition Of Non-Core Australian Drugs From GlaxoSmithKline For US$257 Million 31
Aspen Pharmacare Completes Acquisition Of Non-Core OTC Brands From GlaxoSmithKline For US$263 Million 33
Aspen Pharmacare Acquires Pharma Division Of Sigma Pharma 35
Partnerships 37
Aspen Pharmacare Holdings to Enter into Research Agreement with Far Eastern Federal University 37
AstraZeneca Enters into Co-Marketing Agreement with Aspen 38
ANI Pharma Enters into Distribution Agreement with Aspen 39
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 40
Navamedic Amends Distribution Agreement With Aspen Pharma 41
Cipla Plans To Enters Into Co-Development Agreement With Aspen Pharmacare 42
Licensing Agreements 43
Aspen Pharmacare Australia Enters into Licensing Agreement with Neurim Pharma 43
Aspen Pharma Enters into Licensing Agreement with Starpharma 44
Iroko Pharma Enters into Licensing Agreement with Aspen Pharma for Zorvolex 45
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 46
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 47
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 48
Tibotec Pharma Enters Into Licensing Agreement With Aspen Pharmacare For TMC278 49
Equity Offering 50
Aspen Pharmacare Raises USD624 Million in Private Placement of Shares 50
Asset Transactions 52
Endo International Acquires Portfolio of Branded and Generic Products 52
Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 53
Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 54
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 55
Mylan to Acquire Rights to Arixtra Injection from Aspen Global 56
Perrigo Acquires OTC Products From Aspen Global For US$51 Million 57
Lupin Acquires Worldwide Rights To Goanna Brand From Aspen Pharmacare 58
Acquisition 59
GlaxoSmithKline to Acquire 25% Stake in Aspen Japan 59
GlaxoSmithKline Completes Sale Of 6.19% Stake In Aspen Pharmacare For US$696.5 Million 60
Aspen Pharmacare Completes Acquisition Of Remaining 40% Stake In Shelys Africa For US$18.6 Million 62
Aspen Pharmacare Holdings Ltd – Key Competitors 63
Aspen Pharmacare Holdings Ltd – Key Employees 64
Aspen Pharmacare Holdings Ltd – Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Joint Venture 67
Recent Developments 68
Financial Announcements 68
Sep 14, 2017: Aspen increases revenue by 16% to R41.2 billion 68
Mar 09, 2017: Aspen: Unaudited interim financial results for the six months ended 31 December 2016 71
Sep 14, 2016: Aspens comparable revenue increases by 12% to R35.4 billion 74
Mar 03, 2016: Aspen’s profit after tax increases by 35% 76
Legal and Regulatory 79
Jun 13, 2017: Aspen: South African Competition Commission Announcement 79
May 15, 2017: Aspen: Opening of European Commission proceedings 80
Apr 24, 2017: Aspen’s response to the reported Competition Commission investigation 81
Government and Public Interest 82
May 15, 2017: Antitrust: Commission opens formal investigation into Aspen Pharma’s pricing practices for cancer medicines 82
Other Significant Developments 84
Mar 01, 2017: Aspen – Trading Statement 84
Appendix 85
Methodology 85
About GlobalData 85
Contact Us 85
Disclaimer 85
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Aspen Pharmacare Holdings Ltd, Deals By Therapy Area, 2011 to YTD 2017 10
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Aspen to Acquire Remaining Rights to Anaesthetic Portfolio from Astrazeneca 16
Aspen Japan Acquires Four Ethical Drug Brands from Kyowa Hakko Kirin 17
Aspen Pharmacare Acquires Anaesthesia Portfolio from GlaxoSmithKline 18
Aspen Global to Acquire Rights to Hydroxyprogesterone Caproate Injection form McGuff Pharma 19
Aspen Pharmacare Acquires Southern African Operations and Product Rights from Norgine 20
Aspen Pharmacare Plans to Acquire Infant Nutrition Business 21
Aspen Pharmacare to Acquire Rights to Mono-Embolex from Novartis 22
Aspen Pharma Acquires Infant Nutritional Businesses from Nestle for USD180 Million 23
Aspen Acquires Portfolio of Drugs from Merck for USD600 Million 25
Aspen Pharmacare Completes Acquisition of Thrombosis Brands And Manufacturing Facility from GlaxoSmithKline for USD1.13 Billion 28
Aspen Acquires Active Pharmaceutical Ingredients Business From Merck 30
Aspen Completes Acquisition Of Non-Core Australian Drugs From GlaxoSmithKline For US$257 Million 31
Aspen Pharmacare Completes Acquisition Of Non-Core OTC Brands From GlaxoSmithKline For US$263 Million 33
Aspen Pharmacare Acquires Pharma Division Of Sigma Pharma 35
Aspen Pharmacare Holdings to Enter into Research Agreement with Far Eastern Federal University 37
AstraZeneca Enters into Co-Marketing Agreement with Aspen 38
ANI Pharma Enters into Distribution Agreement with Aspen 39
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 40
Navamedic Amends Distribution Agreement With Aspen Pharma 41
Cipla Plans To Enters Into Co-Development Agreement With Aspen Pharmacare 42
Aspen Pharmacare Australia Enters into Licensing Agreement with Neurim Pharma 43
Aspen Pharma Enters into Licensing Agreement with Starpharma 44
Iroko Pharma Enters into Licensing Agreement with Aspen Pharma for Zorvolex 45
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 46
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 47
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 48
Tibotec Pharma Enters Into Licensing Agreement With Aspen Pharmacare For TMC278 49
Aspen Pharmacare Raises USD624 Million in Private Placement of Shares 50
Endo International Acquires Portfolio of Branded and Generic Products 52
Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 53
Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 54
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 55
Mylan to Acquire Rights to Arixtra Injection from Aspen Global 56
Perrigo Acquires OTC Products From Aspen Global For US$51 Million 57
Lupin Acquires Worldwide Rights To Goanna Brand From Aspen Pharmacare 58
GlaxoSmithKline to Acquire 25% Stake in Aspen Japan 59
GlaxoSmithKline Completes Sale Of 6.19% Stake In Aspen Pharmacare For US$696.5 Million 60
Aspen Pharmacare Completes Acquisition Of Remaining 40% Stake In Shelys Africa For US$18.6 Million 62
Aspen Pharmacare Holdings Ltd, Key Competitors 63
Aspen Pharmacare Holdings Ltd, Key Employees 64
Aspen Pharmacare Holdings Ltd, Other Locations 65
Aspen Pharmacare Holdings Ltd, Subsidiaries 65
Aspen Pharmacare Holdings Ltd, Joint Venture 67